Cargando…
Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19
BACKGROUND: In 2020, a new coronavirus, SARS-CoV-2, quickly spread worldwide within a few months. Although coronaviruses typically infect the upper or lower respiratory tract, the virus RNA can be detected in plasma. The risk of transmitting coronavirus via transfusion of blood products remains. As...
Autores principales: | Jin, Changzhong, Yu, Bin, Zhang, Jie, Wu, Hao, Zhou, Xipeng, Yao, Hangping, Liu, Fumin, Lu, Xiangyun, Cheng, Linfang, Jiang, Miao, Wu, Nanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050991/ https://www.ncbi.nlm.nih.gov/pubmed/33863281 http://dx.doi.org/10.1186/s12879-021-05993-0 |
Ejemplares similares
-
Retraction Note to: Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19
por: Jin, Changzhong, et al.
Publicado: (2021) -
Novel Reassortant Influenza A(H5N8) Viruses in Domestic Ducks, Eastern China
por: Wu, Haibo, et al.
Publicado: (2014) -
Genetic and molecular characterization of H9N2 and H5 avian influenza viruses from live poultry markets in Zhejiang Province, eastern China
por: Wu, Haibo, et al.
Publicado: (2015) -
Comparison of a New Gold Immunochromatographic Assay for the Rapid Diagnosis of the Novel Influenza A (H7N9) Virus with Cell Culture and a Real-Time Reverse-Transcription PCR Assay
por: Jin, Changzhong, et al.
Publicado: (2014) -
Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro
por: Shi, Danrong, et al.
Publicado: (2022)